THEMISMED vs VIYASH: Stock Comparison

THEMIS MEDICARE vs VIYASH SCIENTIFICUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

VIYASH SCIENTIFIC is the larger company by market capitalisation. THEMIS MEDICARE shows a lower P/E and faster revenue growth, while VIYASH SCIENTIFIC shows a higher ROE, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

THEMISMED leads 4; VIYASH leads 7 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

THEMISMEDVIYASH

Valuation lens

What price are you paying?

Market CapContext only
₹1,187 Cr
₹11,228 Cr
P/E RatioTHEMISMED has the lower reading
30.51x
61.63x
P/B RatioTHEMISMED has the lower reading
3.06x
3.86x
EPSTHEMISMED has the higher reading
₹3.12
₹1.51
Book ValueContext only
₹43.28
₹71.3
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
VIYASH is the larger company
₹11,228 Cr vs ₹1,187 Cr
P/E Ratio
THEMISMED has a lower P/E
30.51x vs 61.63x
P/B Ratio
THEMISMED has a lower P/B
3.06x vs 3.86x
EPS
THEMISMED has higher earnings per share
₹3.12 vs ₹1.51
Revenue Growth (TTM YoY)
THEMISMED has faster revenue growth
6.7% vs 0%
Qtr Sales Growth
VIYASH has stronger quarterly sales growth
167.57% vs 0%
Qtr Profit Growth
VIYASH has stronger quarterly profit growth
279.02% vs 16.76%
ROE
VIYASH has a higher ROE
4.88% vs -4.71%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricTHEMISMEDVIYASH
SectorHealthcare
IndustryPharmaceuticals

Price

MetricTHEMISMEDVIYASH
Live Price₹128.25₹257.6
Day Change-2.89%-1.09%
Volume1.11 L18.6 L
52-Week High₹148₹298
52-Week Low₹64.95₹178.13
Distance from 52W High-13.34%-13.56%

Valuation

MetricTHEMISMEDVIYASH
Market Cap₹1,187 Cr₹11,228 Cr
P/E Ratio30.51x61.63x
P/B Ratio3.06x3.86x
EPS₹3.12₹1.51
Book Value₹43.28₹71.3
Dividend Yield0%0%

Growth

MetricTHEMISMEDVIYASH
Revenue Growth (TTM YoY)6.7%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%167.57%
Qtr Profit Growth16.76%279.02%

Profitability & Leverage

MetricTHEMISMEDVIYASH
ROE-4.71%4.88%
ROCE-0.63%4.99%
Net Margin0.33%6.57%
Operating Margin-0.79%11.72%
Debt to Equity0.33x0.14x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricTHEMISMEDVIYASH
Promoter Holding57.5%0%
FII Holding0.01% 0.1 pp4.5% 1.56 pp
DII Holding0.01%3.75% 4.24 pp
Public Holding32.87% 0.09 pp30.34% 2.67 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: THEMIS MEDICARE and VIYASH SCIENTIFIC.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.